title: Chelators for copper radionuclides in positron emission tomography radiopharmaceuticals.
abstract: The development of chelating agents for copper radionuclides in positron emission tomography radiopharmaceuticals has been a highly active and important area of study in recent years. The rapid evolution of chelators has resulted in highly specific copper chelators that can be readily conjugated to biomolecules and efficiently radiolabeled to form stable complexes in vivo. Chelators are not only designed for conjugation to monovalent biomolecules but also for incorporation into multivalent targeting ligands such as theranostic nanoparticles. These advancements have strengthened the role of copper radionuclides in the fields of nuclear medicine and molecular imaging. This review emphasizes developments of new copper chelators that have most greatly advanced the field of copper-based radiopharmaceuticals over the past 5 years.
authors.affiliation: Department of Radiology, University of Pittsburgh, Pittsburgh, PA, 15219, USA.
authors.forename: Zhengxin
authors.initials: Z
authors.lastname: Cai
authors.forename: Carolyn J
authors.initials: CJ
authors.lastname: Anderson
mesh_terms: D000818:Animals; D002614:Chelating Agents / Q000737:chemistry*; D057930:Click Chemistry; D003301:Copper Radioisotopes / Q000737:chemistry*; D049268:Positron-Emission Tomography / Q000379:methods*; D019275:Radiopharmaceuticals / Q000737:chemistry*
chemical_list: D002614:Chelating Agents; D003301:Copper Radioisotopes; D019275:Radiopharmaceuticals
keywords: PET; chelator; copper 64; molecular imaging; radiopharmaceutical